
Azenta (AZTA) Stock Forecast & Price Target
Azenta (AZTA) Analyst Ratings
Bulls say
Azenta is a well-established life sciences company that operates in multiple global markets, with a diverse portfolio including cutting-edge sample management solutions and genomic analysis services. Despite missing consensus in FQ26, the company has taken a conservative approach in its lowered guidance and balance sheet and strong FCF profile provides protection from further downside. Additionally, potential drivers such as faster outsourcing and stronger earnings growth support a positive outlook for Azenta's stock.
Bears say
Azenta is a company that provides sample exploration and management solutions using automation and cryogenics. Despite a weak market demand for automated and cryo stores, the company's revenue and EPS have missed consensus and their growth has slowed. The company has lowered its revenue growth guidance and extended its LRP, which indicates a negative outlook for its future performance. The bull case scenario predicts higher growth and margin improvement, while the bear case scenario assumes flat or negative revenue growth. The base case calls for moderate growth and improved margins, and the company's potential upside drivers include increased outsourcing and accretive M&A.
This aggregate rating is based on analysts' research of Azenta and is not a guaranteed prediction by Public.com or investment advice.
Azenta (AZTA) Analyst Forecast & Price Prediction
Start investing in Azenta (AZTA)
Order type
Buy in
Order amount
Est. shares
0 shares